Mitochondrial dysfunction in neurodegenerative diseases and drug targets via apoptotic signaling
- PMID: 31288090
- DOI: 10.1016/j.mito.2019.07.003
Mitochondrial dysfunction in neurodegenerative diseases and drug targets via apoptotic signaling
Abstract
Mitochondrial dysfunction is becoming one of the most emerging pathological process in the etiology of neurological disorders. Other common etiologies of the neurological disorders are aging and oxidative stress. Neurodegenerative disorders for instance Huntington's disease, Parkinson's disease, Amyotrophic lateral sclerosis, Epilepsy, Schizophrenia, Multiple sclerosis, Neuropathic pain and Alzheimer's disease involves mitochondrial dysfunction and is regarded as the core of their pathological processes. Most central pathological feature of the neurodegenerative diseases is apoptosis which is regulated by mitochondria. Altered signaling of the apoptotic mechanisms are involved in neurodegeneration. Abnormal levels of these molecular apoptotic proteins promotes the pathogenesis of neurological disorders. Mitochondria are also implicated in the production of reactive oxygen species (ROS). Raised ROS levels initiates the cascade leading to the non-apoptotic death of cells. ROS produced in cells acts as signaling molecules, but when produced in abundance will result in cellular consequences to deoxyribonucleic acid, proteins and lipids, decreased effectiveness of cellular mechanisms, initiation of inflammatory pathways, excitotoxicity, protein agglomeration and apoptosis. Protecting mitochondrial function has been identified as the most effective therapeutic approach to attenuate the pathogenesis of neurodegenerative diseases. This review aims to provide an insight into the mitochondrial dysfunction in the pathogenesis of neurological disorders, alteration in signaling cascades of apoptosis in mitochondrial dysfunction and the therapeutic strategies (both natural and synthetic drugs) targeting these mitochondrial apoptotic pathways and oxidative stress that holds great promise.
Keywords: Mitochondrial apoptotic pathway; Mitochondrial dysfunction; Neurodegenerative disorder; Oxidative stress and neuroprotection.
Copyright © 2019 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
Similar articles
-
Oxidative Stress: A Key Modulator in Neurodegenerative Diseases.Molecules. 2019 Apr 22;24(8):1583. doi: 10.3390/molecules24081583. Molecules. 2019. PMID: 31013638 Free PMC article. Review.
-
Crosstalk between mitochondrial dysfunction, oxidative stress, and age related neurodegenerative disease: Etiologies and therapeutic strategies.Life Sci. 2019 Feb 1;218:165-184. doi: 10.1016/j.lfs.2018.12.029. Epub 2018 Dec 20. Life Sci. 2019. PMID: 30578866 Review.
-
Mitochondrial dysfunction and oxidative stress in Alzheimer's disease, and Parkinson's disease, Huntington's disease and Amyotrophic Lateral Sclerosis -An updated review.Mitochondrion. 2023 Jul;71:83-92. doi: 10.1016/j.mito.2023.05.007. Epub 2023 Jun 1. Mitochondrion. 2023. PMID: 37269968 Review.
-
Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.J Neurol Sci. 2005 Jun 15;233(1-2):145-62. doi: 10.1016/j.jns.2005.03.012. J Neurol Sci. 2005. PMID: 15896810 Review.
-
Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.J Neurol Sci. 2007 Jun 15;257(1-2):221-39. doi: 10.1016/j.jns.2007.01.033. Epub 2007 Apr 25. J Neurol Sci. 2007. PMID: 17462670 Review.
Cited by
-
NanoBubble-Mediated Oxygenation: Elucidating the Underlying Molecular Mechanisms in Hypoxia and Mitochondrial-Related Pathologies.Nanomaterials (Basel). 2023 Nov 30;13(23):3060. doi: 10.3390/nano13233060. Nanomaterials (Basel). 2023. PMID: 38063756 Free PMC article. Review.
-
Altered gene expression in human brain microvascular endothelial cells in response to the infection of influenza H1N1 virus.Anim Dis. 2022;2(1):25. doi: 10.1186/s44149-022-00053-9. Epub 2022 Nov 3. Anim Dis. 2022. PMID: 36345345 Free PMC article.
-
Norketamine, the Main Metabolite of Ketamine, Induces Mitochondria-Dependent and ER Stress-Triggered Apoptotic Death in Urothelial Cells via a Ca2+-Regulated ERK1/2-Activating Pathway.Int J Mol Sci. 2022 Apr 23;23(9):4666. doi: 10.3390/ijms23094666. Int J Mol Sci. 2022. PMID: 35563057 Free PMC article.
-
Aging, oxidative stress and degenerative diseases: mechanisms, complications and emerging therapeutic strategies.Biogerontology. 2023 Oct;24(5):609-662. doi: 10.1007/s10522-023-10050-1. Epub 2023 Jul 30. Biogerontology. 2023. PMID: 37516673 Review.
-
VDAC1 Protein Regulation of Oxidative Damage and Mitochondrial Dysfunction-Mediated Cytotoxicity by Silica Nanoparticles in SH-SY5Y Cells.Mol Neurobiol. 2023 Nov;60(11):6542-6555. doi: 10.1007/s12035-023-03491-9. Epub 2023 Jul 17. Mol Neurobiol. 2023. PMID: 37458989
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical